The FDA approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace with historical levels, an improvement analysts say could lead to increased investment in biotech firms.
Prior to the leak, the telehealth service Aid Access received about 25 requests each day for abortion pills. After the decision was leaked, that number rose to nearly 250.
McKinsey & Co has agreed to pay $78 million to resolve claims by U.S. health insurers and benefit plans that it fueled an epidemic of opioid addiction through its work for drug companies including OxyContin maker Purdue Pharma.
The pill, called Vibratory Ingestible BioElectronic Stimulator, or VIBES for short, stimulates nerve endings that sense stomach expansion, tricking the brain into thinking the stomach is full.
The FDA seized thousands of counterfeit units of the popular drug. Experts say what's happening in the U.S. may be a symptom of a larger, global problem.